Navigation Links
Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease
Date:6/24/2011

% or more as needed to reduce rapid responses.
  • For patients who do not respond adequately, if the hemoglobin has not increased by more than 1 g/dL after 4 weeks of therapy, increase the dose by 25%.
  • For patients who do not respond adequately over a 12-week escalation period, increasing the PROCRIT dose further is unlikely to improve response and may increase risks.  Use the lowest dose that will maintain a hemoglobin level sufficient to reduce the need for RBC transfusions.  Evaluate other causes of anemia.  Discontinue PROCRIT if responsiveness does not improve.

  • For patients with CKD on dialysis:

    • Initiate PROCRIT treatment when the hemoglobin level is less than 10 g/dL.
    • If the hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt the dose of PROCRIT.
    • The recommended starting dose for adult patients is 50 to 100 Units/kg 3 times weekly intravenously or subcutaneously.  For pediatric patients, a starting dose of 50 Units/kg 3 times weekly intravenously or subcutaneously is recommended.  The intravenous route is recommended for patients on hemodialysis.

    For patients with CKD not on dialysis:

    • Consider initiating PROCRIT treatment only when the hemoglobin level is less than 10 g/dL and the following considerations apply:
      • The rate of hemoglobin decline indicates the likelihood of requiring a RBC transfusion and,
      • reducing the risk of alloimmunization and/or other RBC transfusion-related risks is a goal.
    • If the hemoglobin level exceeds 10 g/dL, reduce or interrupt the dose of PROCRIT, and use the lowest dose of PROCRIT sufficient to reduce the need for RBC transfusions.
    • The recommended starting dose for adult patients is 50 to 100 Units/kg 3
      '/>"/>

    SOURCE Janssen Products, LP
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
    2. Record Breaking $327 Million Verdict Announced in Janssen Case
    3. MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
    4. Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health
    5. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
    6. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
    7. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
    8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
    9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
    10. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
    11. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... FRANKFURT AM MAIN, Germany , ... Risk App from Merz Pharmaceuticals is available free of charge ... risk for getting dementia within the next two decades. Using ... physicians discuss preventive measures with patients at risk. ... and Incidence of DEmentia) has been developed in collaboration with ...
    (Date:8/27/2014)... China, Aug. 28, 2014 China Nepstar ... or the "Company"), a leading retail drugstore chain ... operated stores, today announced its unaudited financial results ... Financial HighlightsFor the quarter ended June 30, 2014: ... million (US$110.7 million) compared to RMB638.8 million in the ...
    (Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
    Breaking Medicine Technology:CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4
    ... (Nasdaq: PRGO ; TASE) today announced that it ... foam brought by Stiefel Research Australia Pty. Ltd., a GSK ... in the U. S., a generic version of Men,s Rogaine® ... Rogaine® (Minoxidil) Foam is used to regrow ...
    ... Informex , the leading meeting place for buyers ... applications, today announced details of its second Latin American Green ... The event will be held in September 2011, with further ... 2011 event follows the success of the inaugural Informex Latin ...
    Cached Medicine Technology:Perrigo Announces Settlement of Rogaine® Foam Patent Litigation 2Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 2Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 3
    (Date:8/28/2014)... 28, 2014 In the healthcare industry, ... practices struggle with: How can the overall quality of ... study of the healthcare industry tackles this question, and ... employee job satisfaction and the quality of patient care. ... found in “ Organizational Factors related to Improving Quality ...
    (Date:8/28/2014)... (PRWEB) August 28, 2014 DoctorBase ... and mid-sized healthcare organizations, today announced that it has ... appointment company ZocDoc , to head their sales ... has created a sales management position. , “I’m passionate ... like DoctorBase that already has so much traction and ...
    (Date:8/28/2014)... York (PRWEB) August 28, 2014 An unprecedented ... and neck issues, Cloud 9 Spine offers their resources online ... problems can quickly become a brick wall of discouragement as ... a professional opinion, Cloud 9 Spine offers a ... technology merged with human interaction that sets Cloud 9 Spine ...
    (Date:8/28/2014)... (PRWEB) August 28, 2014 Top ... many web hosting companies and announces Bluehost, HostMonster ... recommended suppliers for the webmasters worldwide who want ... rates. , As the world’s most popular server-side ... and many other general-purpose programs. It is now ...
    (Date:8/28/2014)... Now in its 4th year, Step for ... by two brain aneurysm survivors. The ongoing mission of Step ... to help increase early detection and to help support individuals ... We hope that you will be able to join this ... Annual Step for Hope Run/ Walk on Saturday, September 6, ...
    Breaking Medicine News(10 mins):Health News:New Healthcare Study Explores Strategies for Improving Patient Care 2Health News:New Healthcare Study Explores Strategies for Improving Patient Care 3Health News:New Healthcare Study Explores Strategies for Improving Patient Care 4Health News:DoctorBase Hires Josh Angeles as Vice-President of Sales 2Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2Health News:Step for Hope and Raise Brain Aneurysm Awareness 2
    ... arise sporadically, rather than through inheritance of certain genes, ... allow environmentally triggered mutations to accumulate, according to researchers ... Hospital of UPMC and the University of Pittsburgh Cancer ... online edition of the Proceedings of the National ...
    ... the emergence of an epidemic of obesity and type 2 ... that may affect the risk of metabolic diseases is especially ... tend to have about 30% lower risk of developing late ... to be at lower risk of developing metabolic syndrome ...
    ... Reporter , MONDAY, Nov. 29 (HealthDay News) -- The prescription ... study suggests. But one expert was quick to note ... the pain of arthritis, has been linked in some studies ... So it isn,t yet clear that Celebrex (celecoxib) is an ...
    ... , MONDAY, Nov. 29 (HealthDay News) -- Smoking boosts the ... and those with a genetic risk factor for rheumatoid arthritis ... a new study has found. Researchers evaluated 605 black ... found that those with the disease were slightly more likely ...
    ... The American College of Physicians (ACP) today is sending ... internists speaking in their own words ( ... Congress to avert the scheduled Medicare Sustainable Growth Rate ... the repeated cycle of cuts. The 3-minute and ...
    ... the Psychoimmunology Unit at Lund University is presenting these results ... group led by Dr Lena Brundin, which sees inflammation in ... is a new theory that challenges the prevalent view that ... serotonin and noradrenaline. "However, current serotonin-based medication cures far ...
    Cached Medicine News:Health News:Sporadic breast cancers start with ineffective DNA repair systems, Pitt researchers find 2Health News:Moderate alcohol consumption lowers the risk of metabolic diseases 2Health News:Celebrex Shows Potential in Preventing Some Skin Cancers: Study 2Health News:Celebrex Shows Potential in Preventing Some Skin Cancers: Study 3Health News:Heavy Smoking May Double Rheumatoid Arthritis Risk in Blacks 2Health News:Internists issue heartfelt plea for Congress to help patients by stopping Medicare SGR cuts 2Health News:Internists issue heartfelt plea for Congress to help patients by stopping Medicare SGR cuts 3Health News:Biological changes in suicidal patients 2
    Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
    85 right angled suture passer....
    The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
    ... Labral Anchor is an L-PLA anchor ... soft tissue reattachment to bone. The ... bony contour of the glenoid, optimizing ... Osteo Compression (ROC) design to provide ...
    Medicine Products: